Clinical Research Outside of Teaching Hospitals (RECHNONU)

NCT ID: NCT02903953

Last Updated: 2016-09-16

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

129 participants

Study Classification

OBSERVATIONAL

Study Start Date

2012-01-31

Study Completion Date

2013-05-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The very most part of clinical research in France takes place in teaching hospitals. Advantages to develop it in others hospitals are numerous: access to innovative treatments, improvement of healthcare quality, hospitals' attractiveness, increased inclusion rates and reduced selection bias. The objectives of the study are to report the current situation of clinical research outside of teaching hospitals in France.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The very most part of clinical research in France takes place in teaching hospitals. Advantages to develop it in others hospitals are numerous: access to innovative treatments, improvement of healthcare quality, hospitals' attractiveness, increased inclusion rates and reduced selection bias. The objective the study is report the current situation of clinical research outside of teaching hospitals in France.

A three-stage survey was conducted between January and October 2012 in non-teaching hospitals of North-eastern France. First questionnaires were sent to administrative and medical boards of all hospitals with more than 100 beds, then to head doctors of every department in hospitals with more than 300 beds and finally meetings were organized with clinical research actors of 20 selected hospitals.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Medical Staff, Hospital

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* non-teaching hospitals
* established in north-eastern France

Exclusion Criteria

* more than 100 beds
* for the second stage only:
* less than 300 beds
Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Centre Hospitalier Régional Metz-Thionville

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Christophe GOETZ, MD

Role: STUDY_DIRECTOR

CHR Metz-Thionville

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2012-01Obs-CHRMT

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Cancer and Literacy in Health
NCT05008497 RECRUITING